Buonerba, C.; Iaccarino, S.; Dolce, P.; Pagliuca, M.; Izzo, M.; Scafuri, L.; Costabile, F.; Riccio, V.; Ribera, D.; Mucci, B.;
et al. Predictors of Outcomes in Patients with EGFR-Mutated Non-Small Cell Lung Cancer Receiving EGFR Tyrosine Kinase Inhibitors: A Systematic Review and Meta-Analysis. Cancers 2019, 11, 1259.
https://doi.org/10.3390/cancers11091259
AMA Style
Buonerba C, Iaccarino S, Dolce P, Pagliuca M, Izzo M, Scafuri L, Costabile F, Riccio V, Ribera D, Mucci B,
et al. Predictors of Outcomes in Patients with EGFR-Mutated Non-Small Cell Lung Cancer Receiving EGFR Tyrosine Kinase Inhibitors: A Systematic Review and Meta-Analysis. Cancers. 2019; 11(9):1259.
https://doi.org/10.3390/cancers11091259
Chicago/Turabian Style
Buonerba, Carlo, Simona Iaccarino, Pasquale Dolce, Martina Pagliuca, Michela Izzo, Luca Scafuri, Ferdinando Costabile, Vittorio Riccio, Dario Ribera, Brigitta Mucci,
and et al. 2019. "Predictors of Outcomes in Patients with EGFR-Mutated Non-Small Cell Lung Cancer Receiving EGFR Tyrosine Kinase Inhibitors: A Systematic Review and Meta-Analysis" Cancers 11, no. 9: 1259.
https://doi.org/10.3390/cancers11091259
APA Style
Buonerba, C., Iaccarino, S., Dolce, P., Pagliuca, M., Izzo, M., Scafuri, L., Costabile, F., Riccio, V., Ribera, D., Mucci, B., Carrano, S., Picozzi, F., Bosso, D., Formisano, L., Bianco, R., De Placido, S., & Di Lorenzo, G.
(2019). Predictors of Outcomes in Patients with EGFR-Mutated Non-Small Cell Lung Cancer Receiving EGFR Tyrosine Kinase Inhibitors: A Systematic Review and Meta-Analysis. Cancers, 11(9), 1259.
https://doi.org/10.3390/cancers11091259
